Clinical Trial

AI-Driven Early Detection of Skin Cancer

Study acronym: Skin Cancer
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 26, 2025 (before its estimated December 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
This study evaluates the feasibility and accuracy of an AI-powered mobile platform (NuvanaDx) for early detection of skin cancer, including melanoma, using smartphone-based imaging. The platform is designed to improve access to early diagnosis, reduce waiting times, and support triage into appropriate care pathways.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-08-20; most recent amendment 2025-09-25.
Status change: Not Yet Recruiting → Recruiting 2025-09-25
Trial Details
NCT Number NCT07144306
Lead Sponsor Nuvana Healthcare LTD
Collaborators: National Institute for Health Research, United Kingdom
Conditions Skin Cancer Melanoma
Enrollment 100 participants
Start Date 2025-10-01
Primary Completion 2025-12-01 (estimated)
Study Completion 2026-01-01 (estimated)
Updated on ClinicalTrials.gov 2025-09-26